| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/23/2007 | CN1965915A Method for extracting bitter buckwheat flavone in high purity |
| 05/23/2007 | CN1965898A Compound capsule of red sage root and method for preparing same |
| 05/23/2007 | CN1965882A Medicament for regulating blood pressure |
| 05/23/2007 | CN1965878A Pharmaceutical composition containing aceglutamide and safflower effective ingredients and formulation thereof |
| 05/23/2007 | CN1965870A Pharmaceutical composition containing ligustrazine and effective component of ginkgo leaf and formulation thereof |
| 05/23/2007 | CN1965849A Composition extracted from Chinese medicinals for treating coronary heart disease and method for preparing ingredients thereof |
| 05/23/2007 | CN1965848A Lyophilized powder injection of breviscapinum and preparation process thereof |
| 05/23/2007 | CN1965822A Sustained release formulation of bilobalide-B and preparation process thereof |
| 05/23/2007 | CN1965821A Oral formulation of danshensu and safflower yellow and preparation process thereof |
| 05/23/2007 | CN1965812A Two kinds of tablet of cinnamyl aldehyde and preparation process thereof |
| 05/23/2007 | CN1965811A Sustained release tablet of calcium dobesilate and preparation process thereof |
| 05/23/2007 | CN1965735A Medicinal pillow filled with tartary buckwheat shell and preparation process thereof |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317018C Hypertension-reducing and clearing ointment |
| 05/23/2007 | CN1317011C Medicine for intenerating blood vessel |
| 05/23/2007 | CN1317010C Dripping pill for tonifying heart and kidney and its preparing method |
| 05/23/2007 | CN1316993C Medicine for treating cerebral infarction, coronary heart disease and angina pectoris |
| 05/23/2007 | CN1316992C Medicine for treating heart brain embulus disease and its preparation method |
| 05/23/2007 | CN1316988C Heart disease treating Chinese medicine composition |
| 05/23/2007 | CN1316985C Novel use of extractive from sapan wood |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/23/2007 | CA2568504A1 Local vascular delivery of p13 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220740 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220738 Rifamycin analogs and uses thereof |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220582 Stem cells that transform to beating cardiomyocytes |
| 05/22/2007 | CA2361844C Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2174327C Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 05/22/2007 | CA2157146C Heterocyclyl-benzoylguanidines |
| 05/18/2007 | WO2007056546A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 05/18/2007 | WO2007056497A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | WO2007056496A1 Oxazole and thiazole ppar modulator |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007055397A1 Method of treatment for ischemic heart disease |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055325A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure |
| 05/18/2007 | WO2007055183A1 Benzene derivative or salt thereof |
| 05/18/2007 | WO2007055093A1 Tricyclic compound |
| 05/18/2007 | WO2007054814A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | WO2007054778A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 05/18/2007 | WO2007054514A2 Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure |
| 05/18/2007 | WO2007054451A1 Use of combinations of nitric oxide-releasing aspirin and aspirin for the treatment of cardiovascular diseases |
| 05/18/2007 | WO2007054269A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007011647A3 Inhibitors of mitotic kinesin ksp |
| 05/18/2007 | WO2007008937A3 Adiponectin variants |
| 05/18/2007 | WO2006106438A3 Modulators of ppar activity |
| 05/18/2007 | CA2629376A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | CA2629367A1 Use of pde iii inhibitors and/or calcium sensitizers for the treatment of asymptomatic (occult) heart failure |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2628305A1 Jelly composition |
| 05/18/2007 | CA2626682A1 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent |
| 05/18/2007 | CA2626446A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | CA2626443A1 Oxazole and thiazole ppar modulators |
| 05/18/2007 | CA2624703A1 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/18/2007 | CA2590511A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 05/17/2007 | US20070112065 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070111967 Organosilicon compounds and their use |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111940 Peptide agonists of GLP-1 activity |
| 05/17/2007 | US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 05/17/2007 | US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/16/2007 | EP1785418A1 Pyrazole derivative |
| 05/16/2007 | EP1785144A2 Combinations of bile acids sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
| 05/16/2007 | EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators |
| 05/16/2007 | EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 05/16/2007 | EP1784193A1 Composition and method for treatment and prevention of atherosclerosis |
| 05/16/2007 | EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 05/16/2007 | EP1784181A1 Vegf inhibition |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1263484B1 Coating which promotes endothelial cell adherence |
| 05/16/2007 | CN1964978A Furanopyrimidine compounds effective as potassium channel inhibitors |
| 05/16/2007 | CN1964727A Agent for removing factor causing circulatory dysfunction |
| 05/16/2007 | CN1964705A Methods for interfering with fibrosis |
| 05/16/2007 | CN1964703A Immediate release pharmaceutical tablets with height greater than width |
| 05/16/2007 | CN1962681A A plurality of antineoplastic sapogenin and its injection preparation method |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961949A Chinese medicine for treating coronary heart disease |